wb 4101 has been researched along with Adenoma in 1 studies
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.
Adenoma: A benign epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramsdell, JS | 1 |
| Bethea, CL | 1 |
| Jaffe, RB | 1 |
| Wilson, CB | 1 |
| Weiner, RI | 1 |
1 other study available for wb 4101 and Adenoma
| Article | Year |
|---|---|
Characterization of dopamine and alpha-adrenergic receptors in human prolactin-secreting adenomas with [3H]-dihydroergocryptine.
Topics: Adenoma; Adolescent; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Binding, Compet | 1985 |